{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-074280","form_type":"8-K","ticker":"RNLXY","cik":"0001811115","company_name":"Renalytix plc","filed_at":"2024-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.267363+00:00","generated_at":"2026-06-01T04:09:18.819333+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Medicare finalizes coverage for Renalytix's kidneyIntelX.dkd at $950/test effective Aug 1, 2024","bullets":["Medicare issued final Local Coverage Determination (LCD) for kidneyIntelX.dkd; effective dates of service on/after August 1, 2024.","Established Medicare price is $950 per test; distinct CPT codes published in CMS 2024 Clinical Lab Fee Schedule.","Coverage applies to patients with Type 2 diabetes and Stage 1-3b Chronic Kidney Disease per FDA label.","LCD issued by National Government Services (NGS), a Medicare Administrative Contractor for the company's NYC lab.","CEO expects coverage to prompt additional major insurance decisions and accelerate test adoption."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-074280","json":"https://secwatch.observer/filing/0000950170-24-074280.json","markdown":"https://secwatch.observer/filing/0000950170-24-074280.md","text":"https://secwatch.observer/filing/0000950170-24-074280.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1811115/000095017024074280/0000950170-24-074280-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1811115/000095017024074280/rnlx-20240614.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:09:18.819333+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}